Alimera Sciences (ALIM) director Halak received 6,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Brian K Halak (director at Alimera Sciences Inc., ALIM) reported that they received 6,000 Stock Option (Right to Buy) on Jan 4, 2023.
- Reporting person
- Halak Brian K
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 4, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 6,000 Common Stock1 | +6,000 | - | - | 6,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 6,000 direct
Footnotes from the filing
- 1. Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Halak report in this ALIM Form 4?
Brian K Halak (director at Alimera Sciences Inc., ALIM) reported that they received 6,000 Stock Option (Right to Buy) on Jan 4, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALIM
Earlier insider filings at ALIM
- Jan 6, 2023SEC Form 4 filed by Snisarenko John
- Jan 6, 2023SEC Form 4 filed by Myers C. Daniel
- Jan 6, 2023SEC Form 4 filed by Largent James R
- Jan 6, 2023SEC Form 4 filed by Kong Garheng
- Jan 6, 2023SEC Form 4 filed by Pizzo Peter J. Iii
Keep researching ALIM
- ALIM insider tradesEvery buy and sale reported by Alimera Sciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
ALIM
Alimera Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2010
Get push alerts for ALIM
Full ALIM profile on Quantisnow Follow ALIM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time